In my recent interview with Ausbiz, I discussed the current economic market, highlighting the change in investor perception regarding interest rates and its significant influence on market performance. I assessed the Macquarie conference, noting the impact of JB Hi-Fi (ASX:JBH) and Super Cheap Auto (ASX:SUL) on retailer expectations, and analysed the challenges banks face in improving their net interest margin amid rising competition and costs. 

For investment opportunities, I favour high-quality stocks in growth markets, particularly in healthcare. I mentioned ResMed’s (ASX:RMD) return to historical growth rates, Lendlease’s (ASX:LLC) focus on Australian assets, and Xero’s (ASX:XRO) impressive net cash flow and potential for future earnings. 

You can watch the full interview here: Stocks that are “hot” right now 

The Montgomery Fund and the Montgomery [Private] Fund owns shares in Resmed and Xero. This article was prepared 30 May 2024 with the information we have today, and our view may change. It does not constitute formal advice or professional investment advice. If you wish to trade Resmed or Xero, you should seek financial advice.